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Abstract
Desquamative gingivitis (DG) is characterized by erythematous, epithelial desquama‐
tion, erosion of the gingival epithelium, and blister formation on the gingiva. DG is a 
clinical feature of a variety of diseases or disorders. Most cases of DG are associated 
with mucocutaneous diseases, the most common ones being lichen planus, mucous 
membrane pemphigoid, and pemphigus vulgaris. Proper diagnosis of the underlying 
cause is important because the prognosis varies, depending on the disease. This chapter 
presents the underlying etiology that is most commonly associated with DG. The current 
literature on the diagnostic and management modalities of patients with DG is reviewed.
Keywords: gingival diseases/pemphigus/pemphigoid, benign mucous membrane/lichen 
planus, oral/hypersensitivity/autoimmune diseases
1. Introduction
Manifestations of desquamative gingivitis (DG) include erythematous gingiva, epithelial des‐
quamation, and erosion of the gingival epithelium, as well as blister formation on the gingiva 
[1, 2] (Figure 1). The DG lesions may be localized or generalized and may extend into the 
alveolar mucosa. Similar lesions are often found on the buccal mucosa, tongue, and palate 
in the oral cavity. The signs of DG are clearly different from those of dental plaque‐induced 
gingivitis. Patients having DG may be asymptomatic or symptomatic [3]. Most symptomatic 
patients complain of mild or moderate oral discomfort, gingival soreness, or a burning sensa‐
tion [4, 5]. DG occurs more often in females than males; approximately 80% of the patients 
are female [4–8]. Most patients with DG are middle‐aged and older, although rare cases have 
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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been observed in children [4, 6, 8, 9]. Early investigators believed that there was a single 
etiology for DG. However, it is apparent that the condition is a nonspecific manifestation of 
several diseases or disorders and therefore has multiple etiologies [1, 2]. Most cases of DG are 
associated with mucocutaneous diseases, the most common ones being lichen planus (LP), 
mucous membrane pemphigoid (MMP), and pemphigus vulgaris (PV) [1, 2, 4–8, 10, 11]. A 
variety of other potential causes, such as lupus erythematosus [12], mixed connective tissue 
disease [5, 10], graft versus host disease [13], erythema multiforme [14], epidermolysis bullosa 
[15, 16], epidermolysis bullosa acquisita [17], Kindler syndrome [18], chronic ulcerative sto‐
matitis [10, 19, 20], lichen planus pemphigoides [21, 22], plasmacytosis [23], plasma cell gingi‐
vitis [24], orofacial granulomatosis [25, 26], foreign body granulomas [27], candidal infection 
[28], and linear IgA disease [29, 30], may cause DG lesions. Factitious injury of the gingiva 
may also present with clinical features consistent with DG [31–34], which was suggestive of 
mucocutaneous diseases including MMP [32, 33] or PV [34]. Contact stomatitis due to den‐
tal hygiene products, dental materials, or food flavorings and preservatives may mimic DG 
[1, 11, 25, 35–39], while several systemic disorders, including Crohn’s disease [40], psoriasis 
[41–43], sarcoidosis [44], and adverse drug reactions [38, 45], may possess some but usually 
not all of the clinical features of DG.
2. Diagnosis
It is very important to accurately diagnose diseases or disorders causing DG because the 
prognosis varies widely, depending on the cause. Although PV rarely occurs, it is a poten‐
tially life‐threatening disease, so it is important to diagnose and treat it in its early stages. 
Airway obstruction due to laryngeal scarring and blindness due to conjunctival scarring 
Figure 1. Desquamative lesions on the attached gingiva. Gentle palpation with the periodontal probe elicited some 
desquamation of the gingival surface (positive Nikolsky’s sign).
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would  certainly deteriorate the quality of life for MMP patients. Early recognition and treat‐
ment of the lesions can prevent serious complications. Histopathological examination and 
direct immunofluorescence (DIF) testing of biopsied tissues are often required to deter‐
mine the underlying etiology of DG [6–8, 10]. For histopathological study, the biopsy site 
should be selected from an area of intact epithelium and include perilesional tissue. This 
may require two separate biopsies, one lesional and one non‐lesional. The perilesional tissue 
or non‐lesional biopsy site should show a nonspecific inflammatory response in suspected 
non‐autoimmune disorders such as LP, erythema multiforme, foreign body gingivitis, facti‐
tious disorder, and contact stomatitis [1, 7, 10]. In contrast, the DIF test should be performed 
on normal‐ appearing tissue rather than perilesional sites in suspected autoimmune diseases 
such as MMP, PV, and chronic ulcerative stomatitis [1, 7, 10, 46, 47]. Since immune deposits 
in autoimmune bullous disease are present in all oral tissue, a positive result from DIF tests 
may be obtained from biopsies taken from distant normal mucosa [46]. The DIF test is consid‐
ered to be the best diagnostic evidence for MMP, PV, chronic ulcerative stomatitis, and other 
autoimmune disorders; therefore, DIF testing is often essential in obtaining a final diagnosis 
since clinical features may be so similar [6–8, 10, 47, 48]. On the other hand, DIF findings are 
supportive but not diagnostic for LP, psoriasis, lupus erythematosus, and mixed connective 
tissue disease because the DIF features of these diseases can also be found in other condi‐
tions [6, 10, 48]. A negative result from DIF tests should be anticipated in biopsies of contact 
stomatitis [1].
Biopsy sites appearing to have an intact epithelial surface should be selected. If lesions are 
present at several mucosal sites, including the gingiva, it is usually best not to use the gingiva 
for the biopsy [1, 49, 50]. However, in approximately half of DG cases, the gingiva was the 
only site of involvement [50, 51]. In these cases, the gingiva should be selected for the biopsy. 
Rees and Burkhart [1] described the six steps to be considered when a gingival biopsy is 
required in DG patients. They highlight the importance of careful site selection for gingival 
biopsies in order to obtain diagnostic tissue samples. An inadequate surgical site selection 
may easily lead to the loss of the gingival epithelium, since the biopsied gingival tissue is thin 
and tends to be fragile. The stab‐and‐roll biopsy technique is a procedure specially designed 
to prevent the epithelium from being removed from the biopsy specimen [1, 46, 52]. This 
biopsy technique prevents the occurrence of lateral shear forces. The operator applies gentle 
pressure on the gingiva with the tip of a #15 blade until the bone surface is reached and then 
the blade is rolled from the tip along the entire cutting edge. If a larger specimen is needed, 
the tip of the blade can be repositioned and the rolling stroke extended. The gingival epithe‐
lium was well maintained, and the relationship with the underlying connective tissue was 
diagnostic from the gingiva of DG patients using the stab‐and‐roll biopsy technique [1, 46, 52].
3. Oral mucosal diseases or disorders that are associated with DG
3.1. Lichen planus (LP)
LP is a relatively common, T‐cell‐mediated chronic inflammatory disease of unknown  etiology. LP 
commonly occurs in middle‐aged and older people, and women are affected more  frequently 
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than men [53, 54]. The lesions are found in multiple regions including the skin, genitalia, or 
oral mucosa, although they are confined to the gingiva alone in some cases [53–56] (Figures 2 
and 3). In many instances, atrophic, ulcerative, and bullous forms are combined as erosive LP. 
The reticular, popular, and plaque‐like forms of LP are often asymptomatic, whereas erosive 
forms may be quite painful when a patient is eating spicy foods or performing oral hygiene 
procedures [53–55, 57] (Figures 4–6). For these reasons, erosive LP usually requires treat‐
ment. Histopathologically, specimens may demonstrate hyperortho‐ or hyperparakeratosis, 
degenerative changes to the basal cells, and band‐like subepithelial infiltrate composed of 
lymphocytes [11] (Figure 7). When available, DIF testing is also valuable in establishing the 
diagnosis, although DIF findings are only suggestive, rather than diagnostic, of LP [6, 10, 48, 
58]. Characteristic DIF findings in oral LP include a linear pattern of anti‐fibrin or anti‐fibrino‐
gen in the basement membrane zone and, to a lesser degree, the presence of IgM or IgG depos‐
its in cytoid bodies [6, 10, 48, 58] (Figure 8).
3.2. Mucous membrane pemphigoid (MMP)
MMP is an autoimmune, subepithelial blistering disease that affects mucous membranes. 
Most patients with MMP are between 60 and 80 years of age [59–61]. However, on relatively 
rare occasions, MMP has been reported in children [9]. Women are affected nearly two times 
more frequently than men [59–61]. MMP can involve any oral mucosal site, although the 
gingiva is affected far more often than other oral tissues [52, 59–62] (Figures 9–13). In more 
than half of early developing cases, the gingiva is the only site of lesions [61, 63]. Extraoral 
areas including the conjunctiva, skin, pharynx, nose, larynx, genitalia, anus, and esophagus 
may also be affected [52, 62, 64, 65]. Scarring of the mucous membranes is often considered 
the clinical hallmark of MMP, although scarring is rarely a feature of oral MMP [52, 64, 65]. 
Figure 2. Desquamative gingivitis associated with oral lichen planus. Erythematous lesions on the attached gingiva.
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Multiple target antigens of MMP were identified in cell‐to‐basement membrane adhesion 
components by the presence of circulating autoantibodies in the patients’ serum. These 
antigens include bullous pemphigoid antigens (BP180 and BP230), α6 β4 integrin, type VII 
collagen, and laminin 332 [62, 63, 66, 67]. The loss of cell‐to‐basement membrane adhesion 
Figure 3. Desquamative gingivitis associated with oral lichen planus. Patchy erythematous lesion was found on the 
palatal mucosa.
Figure 4. Desquamative gingivitis associated with oral lichen planus. Reticular lesions of buccal mucosa in addition to 
gingiva.
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caused by these antibodies may result in subepithelial blistering. Histopathologically, MMP 
is characterized by subepithelial bulla formation [11] (Figure 14). During DIF testing, the lin‐
ear deposition of complement component C3, IgG, or other immunoglobulin is observed in a 
linear pattern along the basement membrane zone [48, 62] (Figure 15).
Figure 6. Oral lichen planus patient. The examination revealed diffuse erythematous lesions on the gingiva (A and B). 
Lesions were also found on the buccal mucosa (C) and tongue (D).
Figure 5. Extraoral lesion associated with oral lichen planus. The reticular lesion was observed on the lip.
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3.3. Pemphigus vulgaris (PV)
PV is an autoimmune blistering disease characterized by acantholysis in the epithelium. 
Most patients with PV are middle‐aged and elderly [68–71]. The disease is equally common 
in men and women [71], and it is a potentially life‐threatening disease [72]. Characteristics 
Figure 8. Direct immunofluorescence of oral lichen planus. A linear deposition of fibrinogen at the basement membrane 
zone was found.
Figure 7. Hematoxylin‐eosin‐stained section of oral lichen planus. The basal layer liquefaction and shortened rete ridges 
were found. A band‐like infiltration of lymphocytes in the lamina propria was also observed.
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of the PV lesions are flaccid bulla formation, erosion, and ulceration in the skin or mucosa [1, 
68] (Figures 16–19). PV frequently begins with oral lesions and later progresses to involve the 
skin [73, 74] (Figure 20). Oral lesions are the most common evidence and develop in almost 
all patients having PV [68, 71]. Lesions may affect the gingiva, and occasionally, the gingiva 
is the only site of involvement in early lesions [69, 73–75]. Circulating PV autoantibodies 
Figure 9. Desquamative gingivitis associated with mucous membrane pemphigoid. Ulcerated gingival surface was 
observed.
Figure 10. Desquamative gingivitis associated with mucous membrane pemphigoid. Ulceration of the palatal mucosa.
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in the serum are pathogenic, and they can cause acantholysis in the epithelium [76]. More 
than 50 proteins have been reported to specifically react with pemphigus IgG autoantibodies 
[77], but it has been determined that the principal autoantigens in pemphigus patients are 
desmogleins, which are the components of desmosomes in the epidermis and mucous mem‐
branes [78, 79]. Almost all patients with PV lesions restricted to the oral mucosa have only 
anti‐ desmoglein 3 antibody in the serum, whereas patients with advanced cases involving 
Figure 11. Desquamative lesions featuring gingival erythema associated with mucous membrane pemphigoid.
Figure 12. Localized blister formation on the gingiva associated with mucous membrane pemphigoid.
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the oral mucosa and skin may have both anti‐desmoglein 3 and anti‐desmoglein 1 antibodies 
[73, 74]. Histopathologically, PV is characterized by acantholysis and a suprabasilar split in 
the epithelium [11] (Figure 21). Tzanck cells are often found in intraepithelial clefts [80]. In 
the DIF examination of PV patients, the deposition of IgG and/or C3 is found in the intercel‐
lular spaces of the epithelium [48] (Figure 22).
Figure 13. Desquamative lesions on the attached gingiva associated with mucous membrane pemphigoid.
Figure 14. Hematoxylin‐eosin‐stained section of mucous membrane pemphigoid. A subepithelial blister formation was 
found.
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3.4. Contact hypersensitivity reactions as cause of DG
Localized or generalized DG is sometimes elicited by contact hypersensitivity reactions to 
various foodstuffs, preservatives, oral hygiene products, and dental restorative materials [11, 
25, 35–39, 81]. Toothpaste hypersensitivity reactions may occur in various oral or  perioral 
Figure 15. Direct immunofluorescence of the mucous membrane pemphigoid. A linear deposition of IgG at the basement 
membrane zone was found.
Figure 16. Desquamative gingivitis associated with pemphigus vulgaris. Eroded gingival surface with ragged edges 
was observed.
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sites, but the gingiva was the most common site of onset [24, 35, 36, 39, 81] (Figure 23). 
Erythema has been expressed as a “velvet‐like appearance of the gingiva” or “fiery red gin‐
giva” [35]. Epithelial sloughing is the most common irritant effect associated with toothpastes 
and mouthwashes [1, 2, 35, 82] (Figure 24). Allergy to dental restorative materials usually 
causes localized DG in gingival or other mucosal tissues directly contacting the allergen 
[1, 11]. Gingival contact hypersensitivity lesions are usually not biopsied. However, if a biopsy 
Figure 17. Desquamative gingivitis associated with pemphigus vulgaris. Localized erosions of the palatal mucosa.
Figure 18. Mild erythema and ulceration of gingiva associated with pemphigus vulgaris.
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is performed, these lesions present with non‐specific histopathologic findings with submuco‐
sal perivascular inflammatory cell infiltration [11, 35, 36]. The existence of focal granuloma‐
tous inflammation and/or multinucleated giant cells in the deep layer of the lamina propria 
was also described in some cases studying contact hypersensitivity stomatitis [25, 81]. DIF 
is not indicated because it is routinely negative [11]. To treat contact hypersensitivity reac‐
tions, the allergen should be identified and removed. To do so, patients should be questioned 
Figure 20. Skin involvement in a desquamative gingivitis associated with pemphigus vulgaris.
Figure 19. Pseudomembrane‐covered erosion of buccal mucosa associated with pemphigus vulgaris.
Desquamative Gingivitis
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regarding the type(s) of oral hygiene products they use, and a 1–2‐week food diary may help 
identify causative agents [35]. Patch testing may be required to identify the allergen or to 
confirm a specific allergen in a dental hygiene product or in a dental restoration. Patients 
are considered to have allergic reactions to a relevant allergen if their patch test results are 
Figure 22. Direct immunofluorescence of pemphigus vulgaris. An intercellular deposition of IgG was seen.
Figure 21. Hematoxylin‐eosin‐stained section of pemphigus vulgaris. Acantholys was recognized.
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positive [35, 81]. However, diagnosis of contact hypersensitivity reactions may be confirmed 
simply by the discontinuation of the causative agent(s) resulting in the remission of clinical 
signs and symptoms [35, 36, 81].
Figure 23. Contact hypersensitivity reactions caused by toothpaste. Localized erythematous and edematous lesions were 
found on the gingiva.
Figure 24. Contact hypersensitivity reactions caused by mouth rinse. Epithelial sloughing was noted.
Desquamative Gingivitis
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4. Managing DG patients
The specific disease or disorder causing DG, the severity of the gingival lesions, the pres‐
ence or absence of extraoral involvements, and the medical history of the patient are the 
key factors in determining the selection of a topical or systemic immunosuppressive ther‐
apy [1, 2, 69, 83]. The patients diagnosed as having an autoimmune disease should be 
closely followed because they may require immediate referral to other health care experts 
especially if they develop extraoral lesions. After MMP is diagnosed from DG or con‐
comitant lesions, patients should undergo examination by medical specialists including 
an ophthalmologist and an otolaryngologist, and the presence or absence of extraoral 
lesions should be determined. PV patients with exclusively oral lesions should be fol‐
lowed closely and referred to other experts immediately if they develop lesions elsewhere 
on the body. Management of the specific disease or disorder causing DG may best be 
provided by a specialist in oral medicine, oral pathology, periodontics, or oral surgery, 
but the dentist may still be responsible for maintaining the dental and periodontal health 
of the patient. This is important because periodontal and dental considerations are often 
observed in DG patients, but the literature contains minimal information regarding the 
periodontal and dental management of these individuals. Plaque‐induced gingivitis is 
almost universal in patients with symptomatic DG, and an effective therapeutic protocol 
should include non‐surgical periodontal therapy consisting of oral hygiene instruction, 
scaling, and root planting [2, 84–89] (Figure 25). We believe that excessively vigorous 
scaling and root planting can be unnecessarily damaging to DG‐affected lesions, and we 
prefer a sequential gingival management approach that features gentle supragingival and 
slight subgingival debridement which can be repeated at two‐week intervals resulting 
in gradual improvement in periodontal status until an acceptable level of periodontal 
health has been achieved. The relationship between the existence of DG lesions and the 
progression of periodontal diseases is inconclusive, although some but not all studies 
Figure 25. Desquamative gingivitis associated with mucous membrane pemphigoid. The initial examination 
revealed moderate erythema and swelling of the gingiva with plaque and calculus deposits (A). Treatment response. 
The condition of the gingiva improved due to a topical corticosteroid therapy combined with effective plaque 
control (B).
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demonstrated a correlation between compromised periodontal status and autoimmune 
bullous diseases affecting the mouth [90–96]. There are several reports on periodontal 
surgery or dental implant therapy performed on patients having DG [15–17, 73, 97–100]. 
Tissue sloughing and a lack of tissue elasticity caused by active autoimmune bullous 
disease can disturb the manipulation of the mucosal flap. Strict mucosal disease control 
prior to surgery may reduce the surgical complications [101]. Implant therapy is likely to 
enhance the quality of life in patients with systemic diseases and may help them maintain 
long‐term masticatory function. Patients with DG are often unable to wear  tissue‐borne 
prostheses because of discomfort. This tissue irritation and oral pain can be increased if 
the appliances are ill fitting or damaged. A  dental implant‐ supported prosthesis improves 
the stabilization of the prosthesis, resulting in a higher degree of comfort. Published case 
reports indicated that DG patients can be successfully managed with dental implants. 
These reports suggest that the degree of disease control may be more important than 
the nature of the disease itself in regard to the effects on osseointegration. Penarrocha 
et al. [98] reported that implants can be successfully placed and used to support den‐
tal prostheses in patients with recessive dystrophic epidermolysis bullosa. A total of 
38 implants were placed in six totally edentulous patients. Only one implant failed to 
achieve osseointegration. The average follow‐up from implant placement was 5.5 years. 
The implant‐supported prostheses were associated with improvements in the patients’ 
comfort and function, esthetics and appearance, taste, speech, and self‐esteem. Altin et 
al. [99] presented a case of PV rehabilitation using a successful implant‐supported pros‐
thesis with a 32‐month follow‐up. They concluded that the implant treatment may be 
considered as a good alternative to a tissue‐borne prosthesis in PV patients. Esposito et al. 
[100] reported implant retained overdentures for two patients with severe oral LP. The 
patients were often unable to wear tissue‐borne prostheses because of the discomfort. 
There was good integration of the implants with no clinical or radiographic evidence of 
bone loss, and the soft‐tissue/implant response was excellent. Lesions occasionally flared‐
up but were successfully treated with topical steroids. There was no evidence of potential 
implant failure as a result of these flare‐ups. Although these descriptions of successful 
management using dental implants for patients with DG are promising, further studies 
are needed since these were individual case reports.
5. Conclusion
DG is a clinical manifestation that is common to several diseases or disorders. It is important 
to diagnose the diseases causing DG because the prognosis varies, depending on the dis‐
ease. Histopathological examination and DIF testing are often required to establish the final 
diagnosis. The patients diagnosed with autoimmune diseases such as MMP or PV should 
be closely followed because they must be immediately referred to other experts when they 
develop lesions on parts of their body other than the oral cavity.
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